| abstract |
Imidazoquinoline amine, imidazotetrahydroquinoline amine, imidazopyridine amine, 6,7-fused cycloalkylimidazopyridine amine, 1,2-bridged imidazoquinoline amine, thiazolo-quinolineamine, oxazolo Immune response modifiers (IRM) selected from -quinolineamine, thiazolo-pyridineamine, oxazolo-pyridineamine, imidazonaphthyridine amine, tetrahydroimidazonaphthyridine amine and thiazolonaphthyridine amine; fatty acid; And hydrophobic aprotic components that are miscible with fatty acids, are useful for the treatment of skin related conditions. New topical formulations are provided. In one embodiment, the topical formulation is advantageous for the treatment of actinic keratosis, postoperative scars, basal cell carcinoma, atopic dermatitis and warts. |